Home > RUO Products > ImmunoAssays > Growth Factors > Somatostatin > Somatostatin, RIA, For Research, 100 tests < you are here

Somatostatin, RIA, For Research, 100 tests

The intended use is for determination of somatostatin in human plasma. Somatostatin in plasma is extracted with Sep-pak C18 cartridges. The extracts are analysed by a competitive radioimmunoassay using an antiserum to synthetic cyclic somatostatin 14. Somatostatin in standards and samples compete with 125I-labelled somatostatin in binding to the antibodies. 125I-Tyr1-somatostatin binds in a reverse proportion to the concentration of somatostatin in standards and samples. Antibody-bound 125I-Tyr1-somatostatin is separated from the unbound fraction using the double antibody solid phase precipitation technique. The radioactivity of the precipitates is measured.

Catalog # RB306RUO
Format RIA
Label I125
Size 100 tests
Sample Type Plasma
Sample Volume 1000 µL
Controls 2 levels
Range 3,9-125 pmol/L
Sensitivity 6 pmol/L
Incubation 20-24 hours
Shelf Life (weeks) 12

Iodination Schedule 2015 :

Due to local registration requirement, this product can not be sold in Canada, United States, Australia – without prior registration.

For Japan and Brazil, specific registration requirements are necessary. For more information, please contact: RA@diasource.be.

Documents - Download
Download "Instructions for Use" RB306RUO.pdf
Download "Material Safety Data Sheet" MSRB306RUO.pdf
Download brochure "Growth Factors" CATR.pdf
Download Calendar CAL2020.pdf
Coordinates

DIAsource ImmunoAssays SA
BE 0457.934.723
Rue du Bosquet, 2 | 1348 Louvain-la-Neuve - Belgium
Tel +32 10 84 99 11 | Fax +32 10 84 99 90

CLOSING DAYS 2019 : 1/01-22/04-01&30/05-10/06-21/07-15/08-01&11/11-25/12

Choose my country

DIAsource ImmunoAssays (formerly BioSource), experienced diagnostic manufacturer of RIA-ELISA-LIA immunoassays, validation on automates, large scale production of Antibodies-Point of Care Tests.

Please select your country to see the most accurate content available in your area.